Typically, GLP-1 medications are considered for individuals with a BMI of 30 or greater, which categorizes them as obese
Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements
Consistent use, along with appropriate lifestyle modifications, is important for achieving the desired therapeutic effect
Trials concerning stem cell therapy of DPN are controlled but not placebo-blinded
If you're on a weekly injection protocol and surgery occurs mid-cycle, your provider may adjust your next scheduled dose to accommodate the interruption
Gastrointestinal: Nausea, diarrhea, constipation, reduced appetite, acid reflux General: Fatigue during titration, injection site reactions Less Common: Headache, dizziness, elevated heart rate Slower titration helps those who experience significant nausea